This is additional taxonomy that helps us with analytics
Hoda Kotb to sit down with Jada Pinkett SmithTODAY reveals names of twin tiger cubs at Toledo ZooMGM’s cyberattack cost the company more than $100 millionTropical Storm Phillipe to make landfall on East Coast this weekendBiden administration will resume deporting Venezuelan migrantsPowerball jackpot rises to third largest in game’s historyCDC will no longer distribute COVID-19 vaccination cardsUS women’s gymnastics team wins gold at world championshipBiden cancels an additional $9 billion in...
pancreatitis, bowel obstruction and stomach paralysis. NBC’s Stephanie Gosk reports for TODAY, and Dr. Tara Narula joins with analysis.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic and Wegovy linked to gastrointestinal problems in new researchGabrielle M. Etzel is the healthcare policy reporter for the Washington Examiner. Prior to joining the Washington Examiner, she served as a staff reporter at Campus Reform and as a freelance writer. After graduating from Grove City College, Etzel earned her master's in public policy and administration from Baylor University, where she conducted research on domestic sex trafficking. In her free time, Etzel enjoys being with her family in Pittsburgh, Pennsylvania.
Read more »
Weight Loss Drugs Ozempic and Wegovy Linked to Severe Gut Problems: StudyA small percentage of users may experience severe gastrointestinal side effects.
Read more »
Ozempic, Wegovy linked to severe medical conditions including stomach problems, study findsBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
Wegovy and Ozempic ingredient linked to rare stomach paralysis casesA study involving 16 million people in the US found that those prescribed so-called GLP-1-agonists had an increased risk of serious gastrointestinal conditions, including stomach paralysis
Read more »
New Ozempic danger: FDA updates label to warn users of intestinal blockageThe Food and Drug Administration updated the labeling for Ozempic acknowledging reports of blocked intestines for those that use the medication.
Read more »